HFCAS OpenIR

浏览/检索结果: 共5条,第1-5条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Lipid profiling in malignant mesothelioma reveals promising signatures for diagnosis and prognosis: A plasma-based LC-MS lipidomics study 期刊论文
CLINICA CHIMICA ACTA, 2022, 卷号: 524
作者:  Chen, Zhongjian;  Song, Siyu;  Yang, Chenxi;  Dai, Ziyi;  Gao, Yun;  Li, Na;  Zhu, Jing;  Mao, Weimin;  Liu, Junping
收藏  |  浏览/下载:36/0  |  提交时间:2022/12/23
LC-MS  Malignant mesothelioma  Lipidomics  TG  PC  PE  Ceramide  Biomarker  
Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 11
作者:  Guo, Zhenying;  Shen, Li;  Li, Ningning;  Wu, Xiaoxiao;  Wang, Canming;  Gu, Zheng;  Chen, Zhongjian;  Liu, Junping;  Mao, Weimin;  Han, Yuchen
收藏  |  浏览/下载:74/0  |  提交时间:2022/01/25
malignant mesothelioma  bioinformatics  biomarkers  tissue microarray  Aurora kinase A  
Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma 期刊论文
DIAGNOSTICS, 2021, 卷号: 11
作者:  Li, Na;  Yang, Chenxi;  Zhou, Sicheng;  Song, Siyu;  Jin, Yuyao;  Wang, Ding;  Liu, Junping;  Gao, Yun;  Yang, Haining;  Mao, Weimin;  Chen, Zhongjian
收藏  |  浏览/下载:51/0  |  提交时间:2021/08/30
malignant mesothelioma  metabolomics  machine learning  diagnosis  
Machine learning applied to near-infrared spectra for clinical pleural effusion classification 期刊论文
SCIENTIFIC REPORTS, 2021, 卷号: 11
作者:  Chen, Zhongjian;  Chen, Keke;  Lou, Yan;  Zhu, Jing;  Mao, Weimin;  Song, Zhengbo
收藏  |  浏览/下载:45/0  |  提交时间:2021/08/31
Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Chen, Zhongjian;  Dai, Yalan;  Huang, Xiancong;  Chen, Keke;  Gao, Yun;  Li, Na;  Wang, Ding;  Chen, Aiping;  Yang, Qingxia;  Hong, Yanjun;  Zeng, Su;  Mao, Weimin
收藏  |  浏览/下载:62/0  |  提交时间:2020/11/30
esophageal squamous cell carcinoma (ESCC)  metabolomics  risk score  prognosis  diagnosis  indoleamine 2  3-dioxygenase 1 (IDO1)  artificial intelligence